Ketoprofen

Ketoprofen

SCHEMBL2896

CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PTGS1PTGS2

The experimentally established mechanism targets of Ketoprofen. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 known ✓ P23219 6/20 1.00
PTGS2 known ✓ P35354 6/20 1.00
MAPT P10636 5/20 1.00
SMN1; SMN2 Q16637 3/20 1.00
ALDH1A1 P00352 3/20 1.00
LMNA P02545 3/20 1.00
CXCR1 P25024 2/20 1.00
CXCR2 P25025 2/20 1.00
CYP3A4 P08684 2/20 1.00
RECQL P46063 1/20 1.00
KDM4E B2RXH2 1/20 1.00
HPGD P15428 1/20 1.00
MAPK1 P28482 1/20 1.00
PMP22 Q01453 1/20 1.00
SLC22A6 Q4U2R8 1/20 1.00
HSD17B10 Q99714 1/20 1.00
CXCL8 P10145 1/20 1.00
THPO P40225 1/20 1.00
HIF1A Q16665 1/20 1.00
HTT P42858 3/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
R-Ketoprofen SCHEMBL195303 1.00 PTGS1 (1.00) PTGS1PTGS2MAPTSMN1; SMN2ALDH1A1
Ketoprofen SCHEMBL8577572 1.00 PTGS1 (1.00) PTGS1PTGS2MAPTSMN1; SMN2ALDH1A1
Dexketoprofen SCHEMBL29396875 1.00 PTGS1 (1.00) PTGS1PTGS2MAPTSMN1; SMN2ALDH1A1
Ketoprofen SCHEMBL16757741 1.00 PTGS1 (1.00) PTGS1PTGS2MAPTSMN1; SMN2ALDH1A1
Ketoprofen SCHEMBL679920 1.00 PTGS1 (1.00) PTGS1PTGS2MAPTSMN1; SMN2ALDH1A1
Dexketoprofen SCHEMBL66987 1.00 PTGS1 (1.00) PTGS1PTGS2MAPTSMN1; SMN2ALDH1A1
R-Ketoprofen SCHEMBL29353694 1.00 PTGS1 (1.00) PTGS1PTGS2MAPTSMN1; SMN2ALDH1A1
Ketoprofen SCHEMBL3843886 1.00 PTGS1 (1.00) PTGS1PTGS2MAPTSMN1; SMN2ALDH1A1
Ketoprofen SCHEMBL8754790 1.00 PTGS1 (1.00) PTGS1PTGS2MAPTSMN1; SMN2ALDH1A1
Ketoprofen SCHEMBL23391019 0.98 PTGS1 (0.97) PTGS1PTGS2MAPTSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 112941 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3607938-B1 PHARMACEUTICAL COMPOSITION SOVIC BRKICIC LJILJANA (HR) 2026-05-27 EP claimed
WO-2026106917-A1 EDIBLE TRANSMUCOSAL DRUG DELIVERY METHOD USING AN INTERMEDIATE CAPSULE AS A TEMPORARY VESSEL BioPhysics Pharma, Inc. (US) 2026-05-21 WO claimed
WO-2026102563-A1 DISUBSTITUTED PYRIMIDOPYRROLE ANALOG AND USE THEREOF 深圳湾实验室坪山生物医药研发转化中心 2026-05-21 WO claimed
US-20260139030-A1 CHIMERIC PROTEINS FOR TREATING CUTANEOUS INFLAMMATION SHATTUCK LABS INC (US) 2026-05-21 US claimed
EP-3841097-B1 2,6-BIS(((1H-BENZO[D]IMIDAZOL-2-YL)THIO)METHYL)PYRIDINE AND N2,N6-DIBENZYLPYRIDINE-2,6-DICARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS PHOSPHOINOSITIDE 3-KINASE (PI3K) INHIBITORS FOR TREATING CANCER BIOMEDICAL RES FOUNDATION OF THE ACADEMY OF ATHENS BRFAA (GR) 2026-05-20 EP claimed
CN-122031290-A Percutaneous permeation promoting system and preparation method and application thereof 北京工商大学 2026-05-15 CN claimed
US-20260130928-A1 COMBINATION OF AKR1C3 ACTIVATED ANTICANCER PRODRUG COMPOUND AND ANALGESIC DRUG FOR TREATING CANCER PATIENTS ACCOMPANIED BY PAIN ASCENTAWITS PHARMACEUTICALS LTD (CN) 2026-05-14 US claimed
US-20260132191-A1 METHODS FOR MODULATING ACTIVITY OF IL-18 FOR TREATMENT OF CD4+ T CELL MEDIATED AUTOIMMUNITY AND IMMUNOPATHOLOGY THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) 2026-05-14 US claimed
CN-122005686-A External application medicine for subacute thyroiditis acute stage and preparation method thereof 广东省中医院海南医院 2026-05-12 CN claimed
CN-122028914-A Combination therapy for autoimmune disorders 拜奥海芬治疗学有限公司 2026-05-12 CN claimed
US-4260613-A ANTIINFLAMMATORY, ANTIPYRETIC, ANALGESIC CRINOS INDUSTRIA FARMACOBIOLOGICA S.P.A. (IT) 1981-04-07 US claimed
US-4233315-A M-BENZOYLHYDRATROPIC ACID AND ACETAMINOPHEN MCNEILAB, INC. (US) 1980-11-11 US claimed
US-4230884-A METHYLATION, HYDROLYSIS, WITH CATALYST LEK, TOVARNA FARMACEVTSKIH IN KEMICNIH IZDELKOV, N.SOL.O. (YU) 1980-10-28 US claimed
EP-0017169-A1 Improved anti-inflammatory combinations having reduced ulcerogenicity MERCK & CO. INC. (US) 1980-10-15 EP claimed
EP-0016460-A1 Salicylamide esters having therapeutical activity, process for their preparation and related pharmaceutical composition NEOPHARMED S.p.A. (IT) 1980-10-01 EP claimed
EP-0012621-A1 Analgesic composition comprising acetaminophen as a potentiating agent McNeilab, Inc. (US) 1980-06-25 EP claimed
US-4201870-A Process for the preparation of 2-(3-benzoylphenyl)-propionic acid LEK TOVARNA FARMACEVTSKIH IN KEMICNIH IZDELKOV, N.SOL.O. (YU) 1980-05-06 US claimed
US-4185100-A CORTICOSTEROID AND A HYDROTROPIC ACID DERIVATIVE, ENZYME INHIBITORS JOHNSON & JOHNSON (US) 1980-01-22 US claimed
US-4162364-A ANTIINFLAMMATORY AGENT LEK TOVARNA FARMACEVTSKIH IN KEMICNIH IZDELKOV, N.SOL.O. (YU) 1979-07-24 US claimed
US-4097522-A Synthesis of m-benzoyl-hydratropic acid AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 1978-06-27 US claimed